These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 25714834)

  • 1. Potential contribution of phenotypically modulated smooth muscle cells and related inflammation in the development of experimental obstructive pulmonary vasculopathy in rats.
    Otsuki S; Sawada H; Yodoya N; Shinohara T; Kato T; Ohashi H; Zhang E; Imanaka-Yoshida K; Shimpo H; Maruyama K; Komada Y; Mitani Y
    PLoS One; 2015; 10(2):e0118655. PubMed ID: 25714834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular smooth muscle cell phenotypes in primary pulmonary hypertension.
    Mitani Y; Ueda M; Komatsu R; Maruyama K; Nagai R; Matsumura M; Sakurai M
    Eur Respir J; 2001 Feb; 17(2):316-20. PubMed ID: 11334137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid lowering promotes accumulation of mature smooth muscle cells expressing smooth muscle myosin heavy chain isoforms in rabbit atheroma.
    Aikawa M; Rabkin E; Voglic SJ; Shing H; Nagai R; Schoen FJ; Libby P
    Circ Res; 1998 Nov; 83(10):1015-26. PubMed ID: 9815149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted deletion of PTEN in smooth muscle cells results in vascular remodeling and recruitment of progenitor cells through induction of stromal cell-derived factor-1alpha.
    Nemenoff RA; Simpson PA; Furgeson SB; Kaplan-Albuquerque N; Crossno J; Garl PJ; Cooper J; Weiser-Evans MC
    Circ Res; 2008 May; 102(9):1036-45. PubMed ID: 18340011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intimal smooth muscle cells of porcine and human coronary artery express S100A4, a marker of the rhomboid phenotype in vitro.
    Brisset AC; Hao H; Camenzind E; Bacchetta M; Geinoz A; Sanchez JC; Chaponnier C; Gabbiani G; Bochaton-Piallat ML
    Circ Res; 2007 Apr; 100(7):1055-62. PubMed ID: 17347479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic modulation of smooth muscle cells in lymphoedema.
    Ogata F; Fujiu K; Koshima I; Nagai R; Manabe I
    Br J Dermatol; 2015; 172(5):1286-93. PubMed ID: 25319851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic and diverse changes in the functional properties of vascular smooth muscle cells in pulmonary hypertension.
    Stenmark KR; Frid MG; Graham BB; Tuder RM
    Cardiovasc Res; 2018 Mar; 114(4):551-564. PubMed ID: 29385432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension.
    Abid S; Houssaïni A; Mouraret N; Marcos E; Amsellem V; Wan F; Dubois-Randé JL; Derumeaux G; Boczkowski J; Motterlini R; Adnot S
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):304-12. PubMed ID: 24334871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting connexin 43 prevents platelet-derived growth factor-BB-induced phenotypic change in porcine coronary artery smooth muscle cells.
    Chadjichristos CE; Morel S; Derouette JP; Sutter E; Roth I; Brisset AC; Bochaton-Piallat ML; Kwak BR
    Circ Res; 2008 Mar; 102(6):653-60. PubMed ID: 18239136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of obstructive intimal lesions and their cellular phenotypes in chronic pulmonary hypertension. A morphometric and immunohistochemical study.
    Yi ES; Kim H; Ahn H; Strother J; Morris T; Masliah E; Hansen LA; Park K; Friedman PJ
    Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1577-86. PubMed ID: 11029379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transdifferentiation of pulmonary arteriolar endothelial cells into smooth muscle-like cells regulated by myocardin involved in hypoxia-induced pulmonary vascular remodelling.
    Zhu P; Huang L; Ge X; Yan F; Wu R; Ao Q
    Int J Exp Pathol; 2006 Dec; 87(6):463-74. PubMed ID: 17222214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamic unloading reverses occlusive vascular lesions in severe pulmonary hypertension.
    Abe K; Shinoda M; Tanaka M; Kuwabara Y; Yoshida K; Hirooka Y; McMurtry IF; Oka M; Sunagawa K
    Cardiovasc Res; 2016 Jul; 111(1):16-25. PubMed ID: 27037259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of profilin, cofilin-2 and LIMK2 in cultured pulmonary artery smooth muscle cells and in pulmonary arteries of monocrotaline-treated rats.
    Dai YP; Bongalon S; Tian H; Parks SD; Mutafova-Yambolieva VN; Yamboliev IA
    Vascul Pharmacol; 2006 May; 44(5):275-82. PubMed ID: 16524786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPARγ attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells.
    Zhang LL; Gao CY; Fang CQ; Wang YJ; Gao D; Yao GE; Xiang J; Wang JZ; Li JC
    Cardiovasc Res; 2011 Dec; 92(3):484-93. PubMed ID: 21880694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of Gax gene in hypoxia-induced pulmonary hypertension, proliferation, and apoptosis of arterial smooth muscle cells.
    Xia S; Tai X; Wang Y; An X; Qian G; Dong J; Wang X; Sha B; Wang D; Murthi P; Kalionis B; Wang X; Bai C
    Am J Respir Cell Mol Biol; 2011 Jan; 44(1):66-73. PubMed ID: 20160044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells.
    Nishimura T; Vaszar LT; Faul JL; Zhao G; Berry GJ; Shi L; Qiu D; Benson G; Pearl RG; Kao PN
    Circulation; 2003 Sep; 108(13):1640-5. PubMed ID: 12963647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.
    Nave AH; Mižíková I; Niess G; Steenbock H; Reichenberger F; Talavera ML; Veit F; Herold S; Mayer K; Vadász I; Weissmann N; Seeger W; Brinckmann J; Morty RE
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1446-58. PubMed ID: 24833797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smooth muscle cell proliferation and localization of macrophages and T cells in the occlusive intracranial major arteries in moyamoya disease.
    Masuda J; Ogata J; Yutani C
    Stroke; 1993 Dec; 24(12):1960-7. PubMed ID: 7902623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAR-2 inhibition reverses experimental pulmonary hypertension.
    Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
    Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptin signalling system as a target for pulmonary arterial hypertension therapy.
    Huertas A; Tu L; Thuillet R; Le Hiress M; Phan C; Ricard N; Nadaud S; Fadel E; Humbert M; Guignabert C
    Eur Respir J; 2015 Apr; 45(4):1066-80. PubMed ID: 25745038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.